Unconventional WD40 domain-dependent role of ATG16L1 in the regulation of IL10R (interleukin 10 receptor) endocytosis, trafficking and signaling

Autophagy. 2021 Sep;17(9):2639-2641. doi: 10.1080/15548627.2021.1947606. Epub 2021 Jul 12.

Abstract

ATG16L1 is a critical mediator of macroautophagy/autophagy required for LC3 lipidation and autophagosome formation. However, ATG16L1 has a C-terminal domain including 7 WD40-type repetitions (WD40 domain, WDD) that is unnecessary for the conventional autophagic pathway. Instead, this domain mediates unconventional activities where LC3 is lipidated in atypical subcellular localizations unrelated to canonical double-membrane autophagosomes. The WDD provides a docking surface for molecules including a specific amino acid motif, thus engaging the LC3 lipidation capabilities of ATG16L1 in single-membrane structures. The physiological implications of such atypical activities are poorly characterized. In a recent report we described the improvement of the WDD-binding motif and the identification of transmembrane molecules that harbor this element in their intracellular region. One of them, IL10RB (interleukin 10 receptor subunit beta), binds the WDD after IL10 activation to facilitate endocytosis, early trafficking and signaling of IL10-IL10R complexes without influencing their degradation rate. These results reveal a novel unconventional role of ATG16L1 in cytokine signaling that does not entail a degradative purpose, thus contributing to catalog the physiological roles played by unconventional activities of the autophagic machinery.

Keywords: ATG16L1; IL10R endocytosis and signaling; WD40 domain; cytokine receptor trafficking; cytokine signaling; endocytosis; unconventional autophagy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autophagy* / physiology
  • Autophagy-Related Proteins / metabolism
  • Endocytosis
  • Receptors, Interleukin-10
  • WD40 Repeats*

Substances

  • Autophagy-Related Proteins
  • Receptors, Interleukin-10

Grants and funding

This work was funded by grants from the Ministerio de Ciencia e Innovación of the Spanish Government (Refs. SAF2014-53320-R and SAF2017-88390-R), the Junta de Castilla y León local government (Ref. SA042P17), the Broad Medical Research Program (Crohn’s and Colitis Foundation of America, CCFA; Ref. IBD-0369) and the Fundación Solórzano (Ref. FS/18-2014). The Centro de Investigación del Cáncer is supported by the Programa de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia cofunded by the Castilla y León autonomous government and the European Regional Development Fund (CLC–2017–01). Additional funding comes from the Fondo Europeo de Desarrollo Regional (FEDER) program of the European Union. R.V. and A.F. are the recipients of predoctoral contracts from the Junta de Castilla y León and the University of Salamanca, respectively. I.S.G. was supported by predoctoral fellowships from the Fundación Moraza and the Estrategia Regional de Investigación e Innovación (Junta de Castilla y León and FEDER; Ref. CLC-2017-01). E.T. holds a predoctoral contract from the Formación de Doctores program of the Ministerio de Ciencia, Innovación y Universidades (Spanish Government). Rachid Taouil Hammouti acknowledges a predoctoral grant from the Government of Andorra (Ref. ATC0XX - AND-2019/2020). F.X.P holds a tenured position at the Consejo Superior de Investigaciones Científicas (CSIC, Spain).